Advanced search
Show most relevant results first | Most recent results are first | Show use by person

Search only Neasa HouriganSearch all speeches

Results 441-460 of 6,650 for speaker:Neasa Hourigan

Joint Oireachtas Committee on Health: General Scheme of the Health (Miscellaneous Provisions) Bill 2023: Discussion (8 Nov 2023)

Neasa Hourigan: I want to put some questions about pharmacies myself before the end of my time. While I broadly accept the requirement for this legislation, it is useful for us to be clear about what we are talking about when talking about the rent-a-room scheme. While it is good that we are encouraging people to make the best use of their homes, we are also encouraging a system where people are not in any...

Joint Oireachtas Committee on Health: General Scheme of the Health (Miscellaneous Provisions) Bill 2023: Discussion (8 Nov 2023)

Neasa Hourigan: When the review was done in the UK, it found that the most common substitution was in the area of things like selective serotonin reuptake inhibitors, SSRIs.

Joint Oireachtas Committee on Health: General Scheme of the Health (Miscellaneous Provisions) Bill 2023: Discussion (8 Nov 2023)

Neasa Hourigan: The Department of Health has that capability already.

Joint Oireachtas Committee on Health: General Scheme of the Health (Miscellaneous Provisions) Bill 2023: Discussion (8 Nov 2023)

Neasa Hourigan: What is the level of communication with pharmacists in dealing with patients or customers because SSRIs, even generic substitutions, might affect people differently? Could Ms Seymour talk me through what the communication is from the Department to pharmacists on how they deal with that issue with patients?

Joint Oireachtas Committee on Health: General Scheme of the Health (Miscellaneous Provisions) Bill 2023: Discussion (8 Nov 2023)

Neasa Hourigan: For the sake of clarity, is it the Department or is it a specific body which is issuing guidance to pharmacists around the particular substitution in the case of a shortage?

Joint Oireachtas Committee on Health: General Scheme of the Health (Miscellaneous Provisions) Bill 2023: Discussion (8 Nov 2023)

Neasa Hourigan: The Minister is the final arbiter and is where the buck stops, which is fair enough, but are all of the groups or people listed out by Ms Seymour in the room when the Department is deciding?

Joint Oireachtas Committee on Health: General Scheme of the Health (Miscellaneous Provisions) Bill 2023: Discussion (8 Nov 2023)

Neasa Hourigan: It is the HSE, then, which goes to the Minister with the recommendation.

Joint Oireachtas Committee on Health: General Scheme of the Health (Miscellaneous Provisions) Bill 2023: Discussion (8 Nov 2023)

Neasa Hourigan: Yes, I know as I am just trying to understand how it might work.

Joint Oireachtas Committee on Health: General Scheme of the Health (Miscellaneous Provisions) Bill 2023: Discussion (8 Nov 2023)

Neasa Hourigan: I notice in the UK that it has included a requirement - under what I believe is a separate piece of legislation - for the pharma industry to advise if shortages are imminent. Is that something we are looking at?

Joint Oireachtas Committee on Health: General Scheme of the Health (Miscellaneous Provisions) Bill 2023: Discussion (8 Nov 2023)

Neasa Hourigan: Could Ms Seymour outline for me how that communication might work or happen?

Joint Oireachtas Committee on Health: General Scheme of the Health (Miscellaneous Provisions) Bill 2023: Discussion (8 Nov 2023)

Neasa Hourigan: Yes.

Joint Oireachtas Committee on Health: General Scheme of the Health (Miscellaneous Provisions) Bill 2023: Discussion (8 Nov 2023)

Neasa Hourigan: What is the timeline for that?

Joint Oireachtas Committee on Health: General Scheme of the Health (Miscellaneous Provisions) Bill 2023: Discussion (8 Nov 2023)

Neasa Hourigan: My apologies to Ms Seymour for interrupting as I only have a couple of minutes left.

Joint Oireachtas Committee on Health: General Scheme of the Health (Miscellaneous Provisions) Bill 2023: Discussion (8 Nov 2023)

Neasa Hourigan: When Ms Seymour says "as to what stocks we have" does she mean within the HSE or by the manufacturers?

Joint Oireachtas Committee on Health: General Scheme of the Health (Miscellaneous Provisions) Bill 2023: Discussion (8 Nov 2023)

Neasa Hourigan: We find it difficult in this country to say that we have this many units gross, altogether.

Joint Oireachtas Committee on Health: General Scheme of the Health (Miscellaneous Provisions) Bill 2023: Discussion (8 Nov 2023)

Neasa Hourigan: Is there, or has there been, a concern, even with that European requirement, with regard to the interaction with the competitiveness of particular products? Pharma is a private industry and if it is reporting shortages I can only imagine that that might have an impact. Is there a concern in terms of the legislation as to how it interacts with the pharma industry's private operation as...

Joint Oireachtas Committee on Health: General Scheme of the Health (Miscellaneous Provisions) Bill 2023: Discussion (8 Nov 2023)

Neasa Hourigan: Have there been failures of that?

Joint Oireachtas Committee on Health: General Scheme of the Health (Miscellaneous Provisions) Bill 2023: Discussion (8 Nov 2023)

Neasa Hourigan: Could Ms Seymour expand on that little bit, please?

Joint Oireachtas Committee on Health: General Scheme of the Health (Miscellaneous Provisions) Bill 2023: Discussion (8 Nov 2023)

Neasa Hourigan: These companies, therefore, have not fulfilled the two months requirement, let us say.

Joint Oireachtas Committee on Health: General Scheme of the Health (Miscellaneous Provisions) Bill 2023: Discussion (8 Nov 2023)

Neasa Hourigan: Has any punitive action being taken?

   Advanced search
Show most relevant results first | Most recent results are first | Show use by person

Search only Neasa HouriganSearch all speeches